Aurora Cannabis (ACB) announces the launch of Black Jelly in Poland, expanding the company’s portfolio of medical cannabis products. “Aurora is uniquely positioned to bring this novel proprietary cultivar to the Polish market thanks to the company’s advanced genetic breeding program and unmatched global cultivation excellence,” said Andreas Dotterweich, Senior VP of Aurora Europe. “We deeply understand that prescribers want reliable, high-potency medical cannabis options for their patients, and we’re proud to offer superior products that consistently meet prescriber and patient needs.”
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACB:
- Aurora Cannabis enters distribution partnership with Leafio Australia
- TLRY, CGC, CRON: Cannabis Stocks Jump as U.S. Medicare Considers Coverage
- Aurora Cannabis Reports Strong Q2 2026 Results
- Aurora Cannabis Earnings Call: Record Growth Amid Challenges
- Aurora Cannabis Reports Increased Revenue in Latest Financial Release